<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="albicans), and protozoa that are responsible for human parasitic infections:" exact="malaria" post="(Plasmodium falciparum), sleeping sickness (Trypanosoma brucei), Chagas disease (T."/>
 <result pre="that are responsible for human parasitic infections: malaria (Plasmodium falciparum)," exact="sleeping sickness" post="(Trypanosoma brucei), Chagas disease (T. cruzi), cutaneous (Leishmania amazonensis)"/>
 <result pre="of deaths is attributed to malaria, leishmaniasis, African and American" exact="trypanosomiasis" post="[36]—protozoal parasites that are included in this study. The"/>
 <result pre="new drugs in this field is a health priority because" exact="malaria" post="is the major parasitic infection in many tropical and"/>
 <result pre="that 40% of the world’s population is at risk of" exact="malaria" post="[37]. In addition to the Plasmodium parasite, flagellated parasitic"/>
 <result pre="this sense, T. brucei is a causative agent of African" exact="trypanosomiasis" post="or sleeping sickness, while T. cruzi causes American trypanosomiasis,"/>
 <result pre="T. brucei is a causative agent of African trypanosomiasis or" exact="sleeping sickness," post="while T. cruzi causes American trypanosomiasis, commonly known as"/>
 <result pre="same concentration range with IC50 values around 2 µg/mL. African" exact="trypanosomiasis" post="invariably leads to coma and death if left untreated,"/>
 <result pre="susceptibilities to P. aduncum EO, with the species that cause" exact="visceral leishmaniasis" post="(L. infantum and L. donovani) showing lower IC50 values."/>
 <result pre="to P. aduncum EO, with the species that cause visceral" exact="leishmaniasis" post="(L. infantum and L. donovani) showing lower IC50 values."/>
 <result pre="epithelial tissues, the EO displayed a higher IC50 value. Currently," exact="leishmaniasis" post="affects 12 million people in 98 countries where the"/>
 <result pre="found against Aedes aegypti mosquitoes, the vector of dengue and" exact="yellow fever." post="Antiparasitic effects were more studied against kinetoplastids, including Trypanosoma"/>
 <result pre="derived therapeutics for the treatment of LeishmaniasisPhytomedicine2011181056106910.1016/j.phymed.2011.03.00421596544 2.TiumanT.S.SantosA.O.Ueda-NakamuraT.FilhoB.P.D.NakamuraC.V.Recent advances in" exact="leishmaniasis" post="treatmentInt. J. Infect. Dis.201115e525e53210.1016/j.ijid.2011.03.02121605997 3.PrandoT.B.L.da BaciqueteT.F.VieiraJ.A.C.BressanJ.GasparottoF.M.JesusD.R.Cardozo JuniorE.L.LourençoE.L.B.Gasparotto JuniorA.Amides from"/>
 <result pre="b. rhodesiense and T. b. gambiense) in vitroActa Trop.19976813914710.1016/S0001-706X(97)00079-X9386789 14.TragerW.JensenJ.B.Human" exact="malaria" post="parasites in continuous cultureJ. Parasitol.20059148448610.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;216108535 15.MaklerM.T.RiesJ.M.WilliamsJ.A.BancroftJ.E.PiperR.C.GibbinsB.L.HinrichsD.J.Parasite lactate dehydrogenase as"/>
 <result pre="Tropical DiseasesWorld Health OrganizationGeneva, Switzerland2015 39.ZuccaM.ScuteraS.SavoiaD.New chemotherapeutic strategies against malaria," exact="leishmaniasis" post="and trypanosomiasesCurr. Med. Chem.20132050252610.2174/092986731132004000323210775 40.BrunR.BlumJ.ChappuisF.BurriC.Human African trypanosomiasisLancet201037514815910.1016/S0140-6736(09)60829-119833383 41.SalomonC.J.First century"/>
 <result pre="heros [53] Antiprotozoal activity against L. amazonensisAntibacterial activity against Mycobacterium" exact="tuberculosis" post="[43] Antiprotozoal activity against T. cruzi [5] Cuba Antioxidant"/>
</results>
